- Home
- DAWN vs POOL Comparison
DAWN vs POOL Comparison
Compare DAWN & POOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- POOL
- Stock Information
- Founded
- DAWN 2018
- POOL 1993
- Country
- DAWN United States
- POOL United States
- Employees
- DAWN N/A
- POOL N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- POOL Industrial Specialties
- Sector
- DAWN Health Care
- POOL Consumer Discretionary
- Exchange
- DAWN Nasdaq
- POOL Nasdaq
- Market Cap
- DAWN 624.8M
- POOL 11.6B
- IPO Year
- DAWN 2021
- POOL 1995
- Fundamental
- Price
- DAWN $7.18
- POOL $324.78
- Analyst Decision
- DAWN Strong Buy
- POOL Hold
- Analyst Count
- DAWN 7
- POOL 7
- Target Price
- DAWN $27.86
- POOL $346.43
- AVG Volume (30 Days)
- DAWN 999.9K
- POOL 472.1K
- Earning Date
- DAWN 10-29-2025
- POOL 10-23-2025
- Dividend Yield
- DAWN N/A
- POOL 1.54%
- EPS Growth
- DAWN N/A
- POOL N/A
- EPS
- DAWN N/A
- POOL 10.81
- Revenue
- DAWN $187,638,000.00
- POOL $5,276,415,000.00
- Revenue This Year
- DAWN $12.56
- POOL $1.96
- Revenue Next Year
- DAWN $48.02
- POOL $3.73
- P/E Ratio
- DAWN N/A
- POOL $29.94
- Revenue Growth
- DAWN 2190.50
- POOL N/A
- 52 Week Low
- DAWN $5.64
- POOL $282.22
- 52 Week High
- DAWN $16.76
- POOL $395.60
- Technical
- Relative Strength Index (RSI)
- DAWN 51.39
- POOL 54.14
- Support Level
- DAWN $7.03
- POOL $317.98
- Resistance Level
- DAWN $7.58
- POOL $330.65
- Average True Range (ATR)
- DAWN 0.28
- POOL 7.90
- MACD
- DAWN -0.04
- POOL 0.65
- Stochastic Oscillator
- DAWN 30.80
- POOL 71.63
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.